Frontlight ResearchEarly access
Trial site
Hebei Petrochina Central Hospital
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- COPD3 trials
- Asthma2 trials
- Coronary artery disease1 trial
- Sjögren's disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Mabwell (Shanghai) Bioscience Co., Ltd.1 trial
- Novo Nordisk A/S1 trial
- RemeGen Co., Ltd.1 trial
- Shanghai Xin Huanghe Pharmaceutical Co., Ltd.1 trial
- and 2 more
Running trials
Enrolling by invitation
Recruiting
Not yet recruiting
Recruiting
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD3 recruiting
- Coronary artery disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026